NOV 14, 2019 3:59 PM PST

Specific gut bacteria linked to bowel cancer

New research suggests that the presence of a certain kind of gut bacteria can increase the risk of bowel cancer by as much as 15%. The research is important in that it actually determines a causal effect – not merely an association – meaning that it suggests that certain bacteria in our guts may cause colorectal cancer. Lead author of the study Kaitlin Wade, Ph.D., from the UK’s University of Bristol, presented the research at the National Cancer Research Institute Cancer Conference in Glasgow.

In conducting the study, Wade and fellow researchers analyzed data from several large datasets – collected from the Flemish Gut Flora Project, the German Food Chain Plus study, the PopGen study, and the international Genetics and Epidemiology of Colorectal Cancer Consortium. In total, they compared the genomes of 124,218 individuals to attempt to determine causality between gut bacteria and colorectal cancer.

"Lots of studies in mice and humans have shown an association between the gut microbiome and bowel cancer," explains Wade, "but very few have provided convincing evidence for causality. In other words, it's really difficult to discern whether components of the gut microbiome can cause bowel cancer, whether the disease itself leads to variation in the gut microbiome, or whether the association is due to some other factors that cause variation in both."

The other factors that Wade is referring to include obesity, lack of physical exercise, smoking, high consumption of red meat and fried foods, as well as age, family history, and IBS. Along with gut bacteria, these factors will result in the diagnosis of more than 100,000 new cases of colon cancer and more than 44,000 new cases of rectal cancer in the United States in 2019, making the combined category of these cancers (called colorectal cancer), the third leading cause of cancer death in both men and women.

Photo: New Atlas

To confirm causality, the research team used a statistical method called Mendelian randomization that allowed them to pinpoint how certain bacteria influence health conditions, without having to involve actual individuals’ lives.

Wade explains, "With Mendelian randomization, we use people's natural, randomly inherited genetic variations, which alter levels of bacteria within the gut microbiome, in a way that mimics a randomized trial. In this way, we don't have to edit anyone's gut microbiome directly by giving antibiotics or probiotics in a randomized trial or waste time waiting to see whether people within the population get colorectal cancer. We just need studies that have already got this information measured," she explains.

This analysis determined that a specific kind of bacteria called Bacteroidales increased the risk of bowel cancer by between 2–15%, showing that the presence of Bacteroidales is greater in those people with colorectal cancer. Although this finding is promising, the researchers hope to continue their investigations, stating that more work is needed to broaden our understanding of gut bacteria’s influence on bowel cancer.

Sources: Medical News Today, National Cancer Research Institute 

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 30, 2020
Cancer
Linking an Aggressive Tumor Factor to the Innate Immune Response
MAY 30, 2020
Linking an Aggressive Tumor Factor to the Innate Immune Response
Epithelial Ovarian Cancer (EOC) is a cancer of the fallopian tubes with a low five-year survival rate with a tendency to ...
JUN 06, 2020
Cancer
Developing a Platform to Efficiently Test Antibody-Drug Conjugates
JUN 06, 2020
Developing a Platform to Efficiently Test Antibody-Drug Conjugates
Cancer has been one of the most persistent diseases modern medicine has faced. Due to its nature, treatments are often t ...
JUN 13, 2020
Cancer
Examining Cancers Effect on the Immune System for Prognostic Use
JUN 13, 2020
Examining Cancers Effect on the Immune System for Prognostic Use
Most think of cancer in the context of where it is on the body like breast or pancreatic cancer. There are several more ...
JUL 07, 2020
Cell & Molecular Biology
Anticancer Compound Found in Marine Bacteria
JUL 07, 2020
Anticancer Compound Found in Marine Bacteria
Bacteria live in symbiosis with many animals in the world. These tiny single-celled creatures often play crucial roles i ...
JUL 19, 2020
Drug Discovery & Development
Nanodrug for Treating Invasive Breast Cancer
JUL 19, 2020
Nanodrug for Treating Invasive Breast Cancer
Scientists at the University of Arkansas created a nano-drug that may eradicate triple-negative breast cancer cells. Fin ...
JUL 26, 2020
Cannabis Sciences
Medicinal Cannabis Kills Cancer Cells
JUL 26, 2020
Medicinal Cannabis Kills Cancer Cells
Researchers at the University of Newcastle have found that a modified version of medicinal cannabis can kill and inhibit ...
Loading Comments...